Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5943 USD | -0.62% | -4.25% | -20.29% |
May. 15 | Traws Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.29% | 12.61M | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- TRAW Stock
- News Traws Pharma, Inc.
- Transcript : Onconova Therapeutics, Inc. - Special Call